Company Overview
Snapshot
Founded in August 2014 by Dror Zur, Magentiq Eye operates with 11–50 employees. The company has raised $6.1M across 9 funding rounds from 8 investors. In July 2023, the FDA authorized the marketing of MAGENTIQ-COLO, a cutting-edge AI gastrointestinal lesion software detection system.
Business overview
Magentiq Eye develops an AI-aided colonoscopy solution that leverages deep learning, image processing, and video processing to enhance accuracy and effectiveness in medical diagnostics. Its primary product, MAGENTIQ-COLO, functions as a real-time adjunct to colonoscopy devices, identifying suspicious polyp locations to reduce miss-rates. The company targets the digital healthcare and medical technologies sectors, serving providers in markets across Europe, India, the United States, China, and Japan.
Strategic signal
In February 2024, Magentiq Eye's AI-aided colonoscopy tool, MAGENTIQ-COLO, received approval from a top medical journal, following news that it increases adenoma detection by 7%. This validation from the medical community and demonstrated efficacy signals strong clinical acceptance and potential for broader adoption in the gastroenterology field, reinforcing the company's position as an innovator in AI-driven diagnostic tools.
Log in to access full profile ›Company Intelligence Q&A
- What is Magentiq Eye's primary product?
- Magentiq Eye's primary product is MAGENTIQ-COLO, an AI-aided colonoscopy solution designed to increase adenoma (polyp) detection rates and improve the overall quality of colonoscopy exams.
- When did Magentiq Eye receive FDA authorization for MAGENTIQ-COLO?
- In July 2023, the FDA authorized the marketing of MAGENTIQ-COLO, Magentiq Eye's AI gastrointestinal lesion software detection system.
- Which investors participated in Magentiq Eye's Series A funding round?
- In July 2025, Magentiq Eye raised a Series A funding round with participation from aMoon Fund.
- What was a key finding regarding MAGENTIQ-COLO's performance?
- In February 2024, it was reported that Magentiq Eye's AI-aided colonoscopy tool increases adenoma detection by 7%.
- When did Magentiq Eye secure a SAFE funding round?
- In December 2023, Magentiq Eye secured a SAFE funding round with participation from.